Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Stroke, Acute
Open-data reference.
25 US clinical trials · 11 currently recruiting
Active & Recent Trials
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
Santiago Ortega Gutierrez
NCT06825897
Focused Intensive Repeated Stepping During Inpatient Rehabilitation Poststroke - A Quality Improvement Project
Indiana University
NCT05393661
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
University of Cincinnati
NCT05911568
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
University of Chicago
NCT06094478
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
University of Cincinnati
NCT05338697
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
Philips Clinical & Medical Affairs Global
NCT04701684
Somatic Dysfunction in Patients With Acute Cerebrovascular Disease
University of California, Davis
NCT06605014
Achieving Meaningful Clinical Benchmarks With Ekso Gait Training During Acute Stroke Inpatient Rehabilitation.
Sunnyview Rehabilitation Hospital
NCT05241457
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
Northwestern University
NCT03401762
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
Baylor Research Institute
NCT06569121
ECMO ABI Detection With Hyperfine
Children's Mercy Hospital Kansas City
NCT06469801
Surveying Patient's Interest in Robotic Rehabilitation Device
State University of New York at Buffalo
NCT05417802
Progressive Abduction Loading Therapy
Northwestern University
NCT04118998
Stroke Ready - Optimizing Acute Stroke Care
University of Michigan
NCT03645590
pRESET for Occlusive Stroke Treatment
phenox
NCT03994822
Pilot Study of Acute Stroke Using the Brainpulse™
Jan Medical
NCT03235271
Study of Desmoteplase (International Nonproprietary Name [INN]) in Acute Ischemic Stroke (DIAS-2)
Forest Laboratories
NCT00111852
Personalized Patient and Caregiver Education After Stroke
University of Pennsylvania
NCT05118503
Robot Assisted Virtual Rehabilitation for the Hand Post Stroke (RAVR)
New Jersey Institute of Technology
NCT03569059
Frequency vs Error Augmentation Training in Acute Physical Therapy Post Stroke
Christine Holmstedt
NCT06042179
Plasma Free Fatty Acids Profile As A Diagnostic Tool For Acute Ischemic Stroke
Sanford Health
NCT03618290
Safety and Feasibility of the Infinity Catheter for Radial Access
Rutgers, The State University of New Jersey
NCT04553549
Study of a Neuroprotective Drug to Limit the Extent of Damage From an Ischemic Stroke
David Hess, MD
NCT00630396
Cortical Processes During Walking Post-stroke
University of Florida
NCT05710029
Treating Sleep Apnea Induced Hypoxemia With Oxygen in Acute Stroke Patients
Mayo Clinic
NCT03300063
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 1 |
| Phase 3 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Stroke, Acute Trial Landscape
ClinicalTrials.gov lists 25 US studies indexed under Stroke, Acute, and 11 of those are currently open to recruitment — roughly 44% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Stroke, Acute shows 1 late-stage studies (Phase 3 and Phase 4 combined) alongside 1 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Stroke, Acute is led by Northwestern University with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 25 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Stroke, Acute?
PlainTrial tracks 25 US clinical trials for Stroke, Acute, of which 11 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Stroke, Acute?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.